Mucoepidermoid carcinoma natural history: Difference between revisions
No edit summary |
|||
| Line 19: | Line 19: | ||
* The overall recurrence rate will depend on the stage<ref name="pmid8842902">{{cite journal |vauthors=Plambeck K, Friedrich RE, Schmelzle R |title=Mucoepidermoid carcinoma of salivary gland origin: classification, clinical-pathological correlation, treatment results and long-term follow-up in 55 patients |journal=J Craniomaxillofac Surg |volume=24 |issue=3 |pages=133–9 |year=1996 |pmid=8842902 |doi= |url=}}</ref> | * The overall recurrence rate will depend on the stage<ref name="pmid8842902">{{cite journal |vauthors=Plambeck K, Friedrich RE, Schmelzle R |title=Mucoepidermoid carcinoma of salivary gland origin: classification, clinical-pathological correlation, treatment results and long-term follow-up in 55 patients |journal=J Craniomaxillofac Surg |volume=24 |issue=3 |pages=133–9 |year=1996 |pmid=8842902 |doi= |url=}}</ref> | ||
* Low grade tumors have a 90-98% survival and a low local [[recurrence]] rate | * Low grade tumors have a 90-98% survival and a low local [[recurrence]] rate | ||
* High grade tumors 30-54% surviving, and a high local recurrence rate <ref name="pmid2306346">{{cite journal |vauthors=Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY |title=Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy |journal=Arch. Otolaryngol. Head Neck Surg. |volume=116 |issue=3 |pages=290–3 |year=1990 |pmid=2306346 |doi= |url=}}</ref> | * High grade tumors 30-54% surviving, and a high local recurrence rate<ref name="pmid2306346">{{cite journal |vauthors=Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY |title=Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy |journal=Arch. Otolaryngol. Head Neck Surg. |volume=116 |issue=3 |pages=290–3 |year=1990 |pmid=2306346 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 22:25, 18 February 2016
|
Mucoepidermoid carcinoma Microchapters |
|
Differentiating Mucoepidermoid Carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mucoepidermoid carcinoma natural history On the Web |
|
American Roentgen Ray Society Images of Mucoepidermoid carcinoma natural history |
|
Risk calculators and risk factors for Mucoepidermoid carcinoma natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
If left untreated, patients with mucoepidermoid carcinoma may progress to develop centinel metastasis to adjacent structures. Common complications mucoepidermoid carcinoma include facial deformity. Prognosis will generally depend on the clinical stage, tumor size, and histological grade. The overall recurrence rate will depend on the stage[1] Low grade tumors have a 90-98% survival and a low local recurrence rate.[2]
Natural History
- Most patients with mucoepidermoid carcinoma are initially asymptomatic.
- The symptoms of usually develop in the second or fifth decade of life, and initially patients complain of swallowing problems that is increased upon chewing activity.
- If left untreated, patients with mucoepidermoid carcinoma may progress to develop centinel metastasis to adjacent structures.
Complications
- Common complications of mucoepidermoid carcinoma, include:[1]
- Facial deformity
Prognosis
- Prognosis will generally depend on the clinical stage, tumor size, and histological grade.
- The overall recurrence rate will depend on the stage[1]
- Low grade tumors have a 90-98% survival and a low local recurrence rate
- High grade tumors 30-54% surviving, and a high local recurrence rate[2]
References
- ↑ 1.0 1.1 1.2 Plambeck K, Friedrich RE, Schmelzle R (1996). "Mucoepidermoid carcinoma of salivary gland origin: classification, clinical-pathological correlation, treatment results and long-term follow-up in 55 patients". J Craniomaxillofac Surg. 24 (3): 133–9. PMID 8842902.
- ↑ 2.0 2.1 Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY (1990). "Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy". Arch. Otolaryngol. Head Neck Surg. 116 (3): 290–3. PMID 2306346.